[Preliminary study on transgenic cell sheet with cartilage-derived morphogenetic protein].

Area of Science:

• Biotechnology
• Tissue Engineering
• Regenerative Medicine

Background:

• Bone mesenchymal stem cells (BMSCs) are crucial for tissue regeneration.
• Cartilage-derived morphogenetic protein 1 (CDMP1) plays a vital role in chondrogenesis.
• Adenovirus vectors offer efficient gene delivery for creating transgenic cells.

Purpose of the Study:

• To construct a transgenic cell sheet expressing human CDMP1 (hCDMP1) using an adenovirus vector.
• To evaluate the biological activity and chondrogenic potential of the engineered cell sheet in vitro.

Main Methods:

• BMSCs were isolated and transfected with an adenovirus vector carrying hCDMP1 and enhanced green fluorescent protein (EGFP).
• Cell proliferation was assessed using MTT assay.
• Transgenic cell sheets were cultured for 14 days on temperature-responsive dishes.
• Gene and protein expression of hCDMP1, collagen type II, and glycosaminoglycans (GAGs) were analyzed using RT-PCR, Western blot, and Alcian blue staining.

Main Results:

• High transfection efficiency (up to 90%) was achieved, with successful generation of transgenic cell sheets.
• Transfected cells expressed hCDMP1 and collagen type II, with significant deposition of extracellular matrix and GAGs.
• No significant difference in cell proliferation was observed between groups.

Conclusions:

• Transgenic cell sheets engineered with hCDMP1 exhibit chondrogenic capacity, evidenced by collagen type II and GAG expression.
• This approach offers a promising new strategy for hard tissue reconstruction, potentially overcoming limitations of traditional tissue engineering.
• The technology holds potential for developing dense, tissue-engineered cartilage.